Free Trial

Paychex Is Set Up For Robust Growth In Calander 2021

Paychex Is Set Up For Robust Growth In Calander 2021

Paychex Q3 Earnings Do Not Include March Results 

Considering the strength of the March NFP report we really thought Paychex (NASDAQ: PAYX) would have reported a better quarter. In hindsight, though, that expectation was misplaced because the Paychex Q3 period ended in February and well before the March surge in hiring began. Even the KC Fed’s Labor Market Conditions Index failed to capture the strength, so much so that it included a statement to the effect the February read does not reflect the current state of labor market conditions. 

“These readings likely do not fully describe the state of the labor market at the end of February, as many of the input data series reflect conditions early in the month. In particular, the series does not include the effects of the decrease in new COVID-19 cases or the acceleration in vaccine administration that occurred later in the month ... Therefore, labor market developments in the latter half of February, including the labor market response to recent COVID-19 developments, will likely show up in the March 2021 LMCI readings.”

The takeaway here is simple. Paychex Q3 results weren’t as strong as we thought they could be but Q4 surely will. Hiring has picked up strength and, based on the company’s internal metrics, that strength is going to result in highly leverage revenue and earnings growth the analysts have yet to factor in. In our view, this company is not only set up to beat the consensus but by such a wide margin it will impact the consensus estimates for next year and the year after as well. That situation will drive share prices higher over the long term. 

Paychex Revenue In-Line, Earnings Beat 

Paychex’s 3rd quarter revenue grew sequentially for the 4th quarter to $1.11 billion. This is shy of the YOY comparison by 2.6% but this is the last quarter of hard comps. Not only do we expect the next quarter’s revenue to accelerate sequentially again but the comp to last year is against the calendar Q2 period when shut-downs were at their worst. 

The details we like most show that revenue is down due to a decrease in spending per client associated with smaller workforces and not because of client loss. Regarding client loss, the company says retention is strong and that its client base has actually grown in the last year. In this scenario, coupled with an increase in the number of services offered, the March 2021 wave of hiring should produce accelerating revenue growth in the 4th quarter and revenue above well above the pre-COVID level. 

Moving down, the company was able to reduce and control its expenses over the past year and quarter. This led to a 4% improvement in SG&A expenses and a 1.1% increase in Operating Income. On the bottom line, the improvement in margin can be seen in both the GAAP and adjusted earnings. GAAP EPS of $0.97 beat by a nickel while the adjusted $0.96 beat by $0.04. 

Paychex Dividend Is Attractive And Safe 

Paychex pays an attractively high-yielding dividend that is much safe than it may appear. At face value, the company is paying out 85% of its earnings which is a bit high but there is this to consider. The company has very little debt, more than enough cash to pay it all off, ultra-low leverage, a high coverage ratio, ample FCF, and growing earnings. In our view, this dividend is as safe as they come and one that may see an unexpected increase in the not-too-distant future. 

Shares of Paychex are down -5.0% following the Q3 release and we think this is a knee-jerk reaction to some news that should have been expected. In that light, the stock is offering a potential entry point for new money but we suggest waiting for support to confirm before buying in. The best first target for support is near the $92 level, if that is breached a move to $88 may be in the cards.

Paychex Is Set Up For Robust Growth In Calander 2021

Should you invest $1,000 in Paychex right now?

Before you consider Paychex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paychex wasn't on the list.

While Paychex currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Thomas Hughes
About The Author

Thomas Hughes

Contributing Author

Technical and Fundamental Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Paychex (PAYX)
4.0979 of 5 stars
$144.46+0.3%2.71%30.80Reduce$131.62
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines